Across
- 1. Beta lactamase inhibitor with antibiotic activity against Acinetobacter baumannii
- 2. Cephalosporin that is hydrolyzed by ESBLs, but not AmpC
- 4. Coformulated with ceftazidime for activity against a variety of ESBLs
- 6. Preferred treatment for difficult-to-treat Pseudomonas aeruginosa that are metallo-beta-lactamase producing
- 7. The most common class of carbapenemase in the United States
- 8. Uncomplicated cystitis due to difficult-to-treat Pseudomonas aeruginosa can be treated with a single dose of this aminoglycoside
- 9. Genus of bacteria known to produce AmpC beta lactamase
Down
- 1. Trimethoprim/sulfamethoxazole has more than 90% likelihood of covering this organism
- 3. Tetracycline active against both Stenotrophomonas maltophilia and Acinetobacter baumannii
- 5. First line agent for uncomplicated cystitis secondary to ESBL E. coli